Revvity (NYSE: RVTY) — Company Overview, News & Financial Data
Revvity is a life sciences company that provides products and solutions to enhance research and diagnostics in healthcare.
Revvity
Revvity is a life sciences and diagnostics solutions provider that develops and manufactures analytical instruments, reagents, software, and clinical testing services. The company offers life science research technologies including genomic analysis tools, cellular imaging systems, automated liquid handling, and immunoassay reagents for drug discovery and development. In diagnostics, it provides reproductive health screening, immunodiagnostics, autoimmune disease testing, and pathogen detection systems. Serving pharmaceutical companies, biotechnology firms, clinical laboratories, healthcare professionals, and academic research institutions globally, Revvity supports biomedical research workflows, cell and gene therapy development, and clinical diagnostic testing from preclinical research through market approval.
Snapshot
Operations
Products and/or services of Revvity
- Life Sciences Reagents & Assays: Supplies over 1,700 no-wash immunoassays, fluorescent reagents, cellular imaging reagents, custom microplates, and functional genomics tools, supporting target discovery, drug screening, and cell line engineering across global biotechnology and pharmaceutical laboratories.
- Instruments & Automation Systems: Manufactures automated liquid handling workstations, microplate readers, capillary electrophoresis microfluidic analyzers, high-content cellular imaging instruments, and tissue homogenizers designed for high-throughput drug screening, sample preparation, and biomedical research applications globally.
- Reproductive Health Diagnostics: Produces prenatal and maternal screening assays, cell-free DNA analysis platforms, and automated mass spectrometry systems used by clinical laboratories worldwide to screen more than 33 million newborn infants annually for genetic and metabolic disorders.
- Immunodiagnostics & Pathogen Testing: Supplies diagnostic assays, microplate instruments, and molecular testing kits for autoimmune conditions, infectious diseases, allergies, and endocrinology, including blood testing systems for latent tuberculosis detection and autoimmune disorder analysis.
- Informatics & Scientific Software: Delivers cloud-based electronic lab notebooks, workflow execution platforms, chemical structure drawing tools, and clinical data management software used by over two million research scientists across pharmaceutical, biotechnology, and academic research institutions.
- Genomics & Contract Services: Provides specialized preclinical testing, viral vector engineering and manufacturing, clinical genomics, metabolic profiling, custom assay development, and stem cell banking services to support biopharmaceutical drug development and clinical diagnostic testing globally.
Revvity executive team
- Dr. Prahlad R. Singh Ph.D.CEO, President & Director
- Mr. Maxwell KrakowiakSenior VP & CFO
- Mr. Tajinder S. VohraSenior Vice President of Global Operations
- Mr. Joel S. GoldbergSenior VP of Administration, General Counsel & Secretary
- Ms. Miriame VictorSenior VP & Chief Commercial Officer
- Ms. Anita GonzalesChief Accounting Officer, VP & Controller
- Mr. Bryan A. KippSenior VP of Technology & Licensing
- Ms. Madhuri Hegde FACMG, Ph.D.Senior VP & Chief Scientific Officer
- Mr. Stephen Barr WilloughbySenior VP of Investor Relations & Head of ESG
- Ms. Magali FourSenior VP and Chief People & Culture Officer